Merck & Co Inc

NYSE:MRK   3:59:59 PM EDT
81.55
+0.17 (+0.21%)
Products

FDA Says Molnupiravir Is Not Recommended For Use During Pregnancy

Published: 12/23/2021 14:36 GMT
Merck & Co Inc (MRK) - FDA - Molnupiravir is Not Recommended for Use During Pregnancy.
FDA - Molnupiravir May Cause Fetal Harm When Administered to Pregnant Individuals.
Further Company Coverage: Mrkn ((reuters.
Briefs@thomsonreuters.
Com;)).